Stefan Linn

Oxford Immunotec appointed Stefan Linn its chief operating officer. He was most recently senior vice president, strategy and commercial operations for IMS Health Holdings, where he was responsible for advancing that firm's global growth agenda. Prior to that, he was at TPG Capital , where he helped its healthcare and consumer portfolio firms drive operating improvements.